Thomas M. Coffman, MD, FASN, Past President
Professor Thomas Coffman is Dean of Duke-NUS Medical School and Founding Professor in its Cardiovascular and Metabolic Disorders Signature Research Programme (SRP). He is also the James R. Clapp Professor of Medicine at Duke University School of Medicine where was Chief of the Division of Nephrology and Senior Vice-Chair in the Department of Medicine. An international leader in the field of nephrology, Professor Coffman is a Past-President of the American Society of Nephrology. He is also a member of the American Society for Clinical Investigation and the Association of American Physicians and served on the Nephrology Subspecialty Board of the American Board of Internal Medicine. Professor Coffman has served on a number of editorial boards including Physiological Reviews and Cell Metabolism and currently serves as Associate Editor of the Journal of Clinical Investigation. He is a Fellow of the Councils for High Blood Pressure Research and the Kidney in Cardiovascular Disease of the American Heart Association (AHA) and serves on the Leadership Committee for the AHA Council for High Blood Pressure Research. Professor Coffman also served as Chair of the Steering Committee for the National Institutes of Health (NIH)-funded Animal Models of Diabetes Complications Consortium. His laboratory work has been supported by grants from the NIH and the Department of Veterans' Affairs. Professor Coffman's research interests include the renin-angiotensin and prostanoid systems, and diabetic nephropathy. Professor Coffman was conferred the 2014 Excellence Award for Hypertension Research from the AHA Council on Hypertension recognizing researchers who have made a major impact in the field of hypertension and whose research has contributed to the improved treatment and greater understanding of high blood pressure. He also received the 2014 Distinguished Faculty Award from the Duke Medical Alumni Association as well as the 2022 Alumni Achievement Award from The Ohio State University, College of Medicine. Dr. Coffman currently serves as the lead investigator for DYNAMO (Diabetes studY of Nephropathy And other Microvascular cOmplications), a $25M Large Collaborative Grant funded by the National Medical Research Council of Singapore.